Literature DB >> 19345032

Determination of relative response factors for chromatographic investigations using NMR spectrometry.

Gregory K Webster1, Ian Marsden, Cynthia A Pommerening, Christina M Tyrakowski, Brian Tobias.   

Abstract

In the absence of suitable reference materials for impurity quantitation, laboratories have developed techniques using mass detectors such as the chemical luminescence detector (CLND) and the charged aerosol detector (CAD) to normalize the UV response of each impurity of interest by their molar ratios and thus generate relative response factors without requiring isolated and purified compound-specific standards. While effective, these detectors are limited in response and are effective only with specific mobile phase requirements. Nuclear magnetic resonance (NMR) spectrometry has the advantage of allowing the universal detection of protons while not suffering from the limitations observed for CLND, CAD, and other common detectors. The determination of relative response factors using NMR has been successfully applied to several LC methods. An overview of this technique and representative results are presented.

Mesh:

Substances:

Year:  2009        PMID: 19345032     DOI: 10.1016/j.jpba.2009.02.027

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Prediction of Mass Spectral Response Factors from Predicted Chemometric Data for Druglike Molecules.

Authors:  Christopher J Cramer; Joshua L Johnson; Amin M Kamel
Journal:  J Am Soc Mass Spectrom       Date:  2016-11-10       Impact factor: 3.109

2.  Relative response factors and multiple regression models in liquid chromatography to quantify low-dosed components using alternative standards-proof of concept: total Δ9-THC content in cannabis flowers using CBD as reference.

Authors:  Cedric De Leersnijder; Céline Duchateau; Kris De Braekeleer; Eric Deconinck
Journal:  Anal Bioanal Chem       Date:  2022-07-04       Impact factor: 4.478

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.